what happens when you switch from semaglutide to tirzepatide Switching Between and Tirzepatide: Efficacy, Dosing Protocols, and Expect Switching From Tirzepatide to Semaglutide:

Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (4) reported the occurrence of at least one case of various thyroid disorders as adverse events

Dosing schedules for GLP-1 medications are established through clinical trials that evaluate efficacy, safety, and patient adherence

Benefits seen there may not generalize to non-diabetic populations

If you want a comprehensive medical workup before starting medication, you should look elsewhere